Literature DB >> 32554929

Interferon regulatory factor 1 regulates PANoptosis to prevent colorectal cancer.

Rajendra Karki1, Bhesh Raj Sharma1, Ein Lee1,2, Balaji Banoth1, R K Subbarao Malireddi1, Parimal Samir1, Shraddha Tuladhar1, Harisankeerth Mummareddy1,3, Amanda R Burton1, Peter Vogel4, Thirumala-Devi Kanneganti1.   

Abstract

Interferon regulatory factor 1 (IRF1) regulates diverse biological functions, including modulation of cellular responses involved in tumorigenesis. Genetic mutations and altered IRF1 function are associated with several cancers. Although the function of IRF1 in the immunobiology of cancer is emerging, IRF1-specific mechanisms regulating tumorigenesis and tissue homeostasis in vivo are not clear. Here, we found that mice lacking IRF1 were hypersusceptible to colorectal tumorigenesis. IRF1 functions in both the myeloid and epithelial compartments to confer protection against AOM/DSS-induced colorectal tumorigenesis. We further found that IRF1 also prevents tumorigenesis in a spontaneous mouse model of colorectal cancer. The attenuated cell death in the colons of Irf1-/- mice was due to defective pyroptosis, apoptosis, and necroptosis (PANoptosis). IRF1 does not regulate inflammation and the inflammasome in the colon. Overall, our study identified IRF1 as an upstream regulator of PANoptosis to induce cell death during colitis-associated tumorigenesis.

Entities:  

Keywords:  Cancer; Colorectal cancer; Immunology; Innate immunity; Oncology

Mesh:

Substances:

Year:  2020        PMID: 32554929      PMCID: PMC7406299          DOI: 10.1172/jci.insight.136720

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  58 in total

1.  Proteomics. Tissue-based map of the human proteome.

Authors:  Mathias Uhlén; Linn Fagerberg; Björn M Hallström; Cecilia Lindskog; Per Oksvold; Adil Mardinoglu; Åsa Sivertsson; Caroline Kampf; Evelina Sjöstedt; Anna Asplund; IngMarie Olsson; Karolina Edlund; Emma Lundberg; Sanjay Navani; Cristina Al-Khalili Szigyarto; Jacob Odeberg; Dijana Djureinovic; Jenny Ottosson Takanen; Sophia Hober; Tove Alm; Per-Henrik Edqvist; Holger Berling; Hanna Tegel; Jan Mulder; Johan Rockberg; Peter Nilsson; Jochen M Schwenk; Marica Hamsten; Kalle von Feilitzen; Mattias Forsberg; Lukas Persson; Fredric Johansson; Martin Zwahlen; Gunnar von Heijne; Jens Nielsen; Fredrik Pontén
Journal:  Science       Date:  2015-01-23       Impact factor: 47.728

2.  Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling.

Authors:  Nobuhiko Kayagaki; Irma B Stowe; Bettina L Lee; Karen O'Rourke; Keith Anderson; Søren Warming; Trinna Cuellar; Benjamin Haley; Merone Roose-Girma; Qui T Phung; Peter S Liu; Jennie R Lill; Hong Li; Jiansheng Wu; Sarah Kummerfeld; Juan Zhang; Wyne P Lee; Scott J Snipas; Guy S Salvesen; Lucy X Morris; Linda Fitzgerald; Yafei Zhang; Edward M Bertram; Christopher C Goodnow; Vishva M Dixit
Journal:  Nature       Date:  2015-09-16       Impact factor: 49.962

3.  Stromal myofibroblasts predict disease recurrence for colorectal cancer.

Authors:  Tadashi Tsujino; Iwao Seshimo; Hirofumi Yamamoto; Chew Yee Ngan; Koji Ezumi; Ichiro Takemasa; Masataka Ikeda; Mitsugu Sekimoto; Nariaki Matsuura; Morito Monden
Journal:  Clin Cancer Res       Date:  2007-04-01       Impact factor: 12.531

4.  Pyroptosis and Apoptosis Pathways Engage in Bidirectional Crosstalk in Monocytes and Macrophages.

Authors:  Cornelius Y Taabazuing; Marian C Okondo; Daniel A Bachovchin
Journal:  Cell Chem Biol       Date:  2017-04-06       Impact factor: 8.116

5.  Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways.

Authors:  T Fujita; L F Reis; N Watanabe; Y Kimura; T Taniguchi; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

Review 6.  Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities.

Authors:  Jessica Plati; Octavian Bucur; Roya Khosravi-Far
Journal:  J Cell Biochem       Date:  2008-07-01       Impact factor: 4.429

7.  Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia/leukemia; a possible mechanism of tumor suppressor inactivation.

Authors:  H Harada; T Kondo; S Ogawa; T Tamura; M Kitagawa; N Tanaka; M S Lamphier; H Hirai; T Taniguchi
Journal:  Oncogene       Date:  1994-11       Impact factor: 9.867

8.  Low expression of interferon regulatory factor-1 and identification of novel exons skipping in patients with chronic myeloid leukaemia.

Authors:  Dimitrios Tzoanopoulos; Matthaios Speletas; Konstantinos Arvanitidis; Christina Veiopoulou; Sofia Kyriaki; George Thyphronitis; Paschalis Sideras; Georgios Kartalis; Konstantinos Ritis
Journal:  Br J Haematol       Date:  2002-10       Impact factor: 6.998

Review 9.  The role of myeloid cells in cancer therapies.

Authors:  Camilla Engblom; Christina Pfirschke; Mikael J Pittet
Journal:  Nat Rev Cancer       Date:  2016-07       Impact factor: 60.716

10.  Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach.

Authors:  G Tamura; S Ogasawara; S Nishizuka; K Sakata; C Maesawa; Y Suzuki; M Terashima; K Saito; R Satodate
Journal:  Cancer Res       Date:  1996-02-01       Impact factor: 12.701

View more
  39 in total

Review 1.  The regulation of the ZBP1-NLRP3 inflammasome and its implications in pyroptosis, apoptosis, and necroptosis (PANoptosis).

Authors:  Min Zheng; Thirumala-Devi Kanneganti
Journal:  Immunol Rev       Date:  2020-07-29       Impact factor: 12.988

2.  Advances in Inflammasome Research: Recent Breakthroughs and Future Hurdles.

Authors:  Rebecca E Tweedell; Thirumala-Devi Kanneganti
Journal:  Trends Mol Med       Date:  2020-09-15       Impact factor: 11.951

3.  RIPK1 Distinctly Regulates Yersinia-Induced Inflammatory Cell Death, PANoptosis.

Authors:  R K Subbarao Malireddi; Sannula Kesavardhana; Rajendra Karki; Balabhaskararao Kancharana; Amanda R Burton; Thirumala-Devi Kanneganti
Journal:  Immunohorizons       Date:  2020-12-11

4.  Cutting Edge: Caspase-8 Is a Linchpin in Caspase-3 and Gasdermin D Activation to Control Cell Death, Cytokine Release, and Host Defense during Influenza A Virus Infection.

Authors:  Yaqiu Wang; Rajendra Karki; Min Zheng; Balabhaskararao Kancharana; SangJoon Lee; Sannula Kesavardhana; Baranda S Hansen; Shondra M Pruett-Miller; Thirumala-Devi Kanneganti
Journal:  J Immunol       Date:  2021-10-18       Impact factor: 5.422

Review 5.  Programming inflammatory cell death for therapy.

Authors:  Shelbi Christgen; Rebecca E Tweedell; Thirumala-Devi Kanneganti
Journal:  Pharmacol Ther       Date:  2021-10-04       Impact factor: 12.310

6.  ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis.

Authors:  Rajendra Karki; Balamurugan Sundaram; Bhesh Raj Sharma; SangJoon Lee; R K Subbarao Malireddi; Lam Nhat Nguyen; Shelbi Christgen; Min Zheng; Yaqiu Wang; Parimal Samir; Geoffrey Neale; Peter Vogel; Thirumala-Devi Kanneganti
Journal:  Cell Rep       Date:  2021-10-19       Impact factor: 9.423

7.  Intracellular innate immune receptors: Life inside the cell.

Authors:  Thirumala-Devi Kanneganti
Journal:  Immunol Rev       Date:  2020-09       Impact factor: 12.988

8.  The IFN-inducible GTPase IRGB10 regulates viral replication and inflammasome activation during influenza A virus infection in mice.

Authors:  Shelbi Christgen; David E Place; Min Zheng; Benoit Briard; Masahiro Yamamoto; Thirumala-Devi Kanneganti
Journal:  Eur J Immunol       Date:  2021-11-09       Impact factor: 5.532

9.  Inflammatory Cell Death, PANoptosis, Mediated by Cytokines in Diverse Cancer Lineages Inhibits Tumor Growth.

Authors:  R K Subbarao Malireddi; Rajendra Karki; Balamurugan Sundaram; Balabhaskararao Kancharana; SangJoon Lee; Parimal Samir; Thirumala-Devi Kanneganti
Journal:  Immunohorizons       Date:  2021-07-21

10.  Hierarchical Cell Death Program Disrupts the Intracellular Niche Required for Burkholderia thailandensis Pathogenesis.

Authors:  David E Place; Shelbi Christgen; Shraddha Tuladhar; Peter Vogel; R K Subbarao Malireddi; Thirumala-Devi Kanneganti
Journal:  mBio       Date:  2021-06-22       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.